IRIS
AIMO, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.028
EU - Europa 10.072
AS - Asia 5.056
SA - Sud America 926
AF - Africa 72
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 16
Totale 29.189
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.494
RU - Federazione Russa 4.133
SG - Singapore 2.884
IT - Italia 2.044
GB - Regno Unito 1.234
DE - Germania 836
BR - Brasile 832
CN - Cina 766
HK - Hong Kong 685
CA - Canada 483
IE - Irlanda 422
UA - Ucraina 403
VN - Vietnam 235
FI - Finlandia 226
SE - Svezia 191
FR - Francia 144
NL - Olanda 108
TR - Turchia 88
IN - India 78
AT - Austria 75
PK - Pakistan 68
DK - Danimarca 64
ID - Indonesia 52
BD - Bangladesh 37
AR - Argentina 36
ES - Italia 34
PL - Polonia 31
AE - Emirati Arabi Uniti 30
MX - Messico 29
CH - Svizzera 23
JP - Giappone 23
BE - Belgio 20
LT - Lituania 20
ZA - Sudafrica 19
MA - Marocco 18
EU - Europa 17
RO - Romania 17
UZ - Uzbekistan 17
CZ - Repubblica Ceca 15
IR - Iran 14
CO - Colombia 13
EC - Ecuador 13
VE - Venezuela 12
AU - Australia 11
EG - Egitto 10
IQ - Iraq 9
AZ - Azerbaigian 8
MC - Monaco 8
KE - Kenya 7
AM - Armenia 6
CL - Cile 6
PA - Panama 6
TN - Tunisia 6
KR - Corea 5
PE - Perù 5
SA - Arabia Saudita 5
SK - Slovacchia (Repubblica Slovacca) 5
TW - Taiwan 5
UY - Uruguay 5
GE - Georgia 4
JO - Giordania 4
MY - Malesia 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
OM - Oman 4
TH - Thailandia 4
CI - Costa d'Avorio 3
DZ - Algeria 3
GT - Guatemala 3
HU - Ungheria 3
KG - Kirghizistan 3
KZ - Kazakistan 3
NP - Nepal 3
PH - Filippine 3
PY - Paraguay 3
AO - Angola 2
BH - Bahrain 2
CR - Costa Rica 2
HN - Honduras 2
IL - Israele 2
JM - Giamaica 2
MT - Malta 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
HR - Croazia 1
IS - Islanda 1
Totale 29.180
Salva come PNG Salva come JPEG
Città #
Singapore 1.678
Chicago 1.320
Los Angeles 685
Hong Kong 632
Salt Lake City 586
Chandler 562
Southend 543
Beijing 503
Fairfield 462
San Mateo 451
Moscow 433
Dublin 418
Woodbridge 359
Wilmington 350
Ashburn 344
Tampa 333
Houston 323
Cambridge 316
The Dalles 297
Buffalo 296
Seattle 270
Elk Grove Village 256
Portsmouth 241
Falls Church 237
Boardman 232
Stevenage 215
Ann Arbor 212
Ottawa 203
Beauharnois 193
Milan 190
Pisa 178
Jacksonville 177
Rome 170
Munich 164
Dearborn 156
Lawrence 155
Santa Clara 134
Florence 126
Sterling 124
Dallas 119
Lancaster 119
Dong Ket 117
New York 81
Nuremberg 81
Helsinki 79
Frankfurt am Main 78
London 77
Dulles 76
Miami 74
Brooklyn 70
Istanbul 69
São Paulo 68
Turku 65
San Diego 64
Lappeenranta 60
Detroit 49
Bologna 48
Kansas City 46
Washington 39
Fremont 38
Genoa 36
Palermo 36
Phoenix 36
Livorno 35
Central District 34
Lucca 34
Pittsburgh 33
Vienna 33
Belo Horizonte 32
Naples 30
Toronto 29
Düsseldorf 27
Assago 26
Redwood City 26
San Francisco 26
Rio de Janeiro 24
Warsaw 24
Norwalk 23
Shanghai 23
Guangzhou 22
Las Vegas 22
Old Bridge 21
Bari 19
Brussels 19
Buti 19
Lauterbourg 19
Amsterdam 18
Boston 18
Brasília 18
Mexico City 18
Montreal 18
Padova 18
Redmond 17
Shenzhen 17
Atlanta 16
Curitiba 16
Verona 16
Islamabad 15
Tashkent 15
Turin 15
Totale 16.984
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.714
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.484
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.389
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 745
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 466
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 250
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 220
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 215
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 214
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 211
Treating chemoreflex in heart failure: modulation or demolition? 208
Building medical knowledge from real world registries: The case of heart failure 208
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 201
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 190
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 189
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 188
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 186
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 184
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 176
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 175
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 174
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 173
A simple echocardiographic score to rule out cardiac amyloidosis 166
Cardiac light-chain deposition disease relapsing in the transplanted heart 162
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 161
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 155
Sex-related differences in chronic heart failure 155
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 154
COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead 153
Unmet needs in end-of-life care for heart failure patients 150
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 147
How to take arms against central apneas in heart failure 143
Position paper ANMCO: Impiego di vericiguat nello scompenso cardiaco: dalle evidenze al posizionamento terapeutico 139
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 137
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 136
Exercise intolerance in heart failure with preserved ejection fraction: A reappraisal of central mechanisms? 134
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 134
Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry 133
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 128
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 127
Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure 126
Is fat good for arrhythmias in ischemic heart failure? Another face of the obesity paradox 126
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 124
Cardiac troponins as biomarkers for cardiac disease 123
Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction 122
Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction 121
Screening the health status of people working in a university 120
Heart, kidney and FGF23: Les liaisons dangereuses 119
Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis 119
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 118
Noncardiovascular death after acute heart failure. Do not lose the war while fighting for the failing heart 117
High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure 116
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 115
The Importance of Visceral Feedbacks: Focus on Chemoreceptors 114
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 114
A simple echocardiographic score to rule out cardiac amyloidosis 112
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 112
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 112
Amiodarone as a possible therapy for coronavirus infection 112
Biomarkers for the diagnosis and management of heart failure 109
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 108
Atrial amyloidosis: mechanisms and clinical manifestations 107
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 107
Healthy hearts at hectic pace: From daily life stress to abnormal cardiomyocyte function and arrhythmias 106
Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis 106
The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers 104
Management of complications of cardiac amyloidosis: 10 questions and answers 104
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis 104
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT−proBNP and High-Sensitivity Troponin T 103
Polymorphisms in the eNOS gene and the risk of coronary artery disease: Making the case for genome-wide association studies 101
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 101
Cardiac protection by pirfenidone after myocardial infarction: a bioinformatic analysis 100
N-terminal fraction of pro-B-type natriuretic peptide versus clinical risk scores for prognostic stratification in chronic systolic heart failure 100
The prognostic benefit of cardiac resynchronization therapy is greater in concordant vs. discordant left bundle branch block in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT) 99
Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction 99
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 99
The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target? 98
Cardiovascular disease and COVID-19: les liaisons dangereuses 98
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 97
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 97
Subclinical cardiac damage in cancer patients before chemotherapy 96
Role of Imaging in Cardiomyopathies 95
Sex-related differences in chronic heart failure 95
Biomarkers for the diagnosis and management of heart failure: New frontiers 95
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure 95
Eligibility for vericiguat in a real‐world, contemporary heart failure population 94
Therapies for cardiac light chain amyloidosis: An update 94
ANMCO/ELAS/SIBioC Consensus Document: Biomarkers in heart failure 94
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction 93
Left ventricular ejection fraction for risk stratification in chronic systolic heart failure 91
Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome 91
Molecular autopsy of sudden cardiac death in the genomics era 91
Clinical and Prognostic Significance of sST2 in Heart Failure: JACC Review Topic of the Week 90
Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis 90
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides 90
Factors for heterogeneous outcomes of angina and myocardial ischemia without obstructive coronary atherosclerosis 90
Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis 90
Quality of life and outcome in heart failure with preserved ejection fraction: When sex matters 89
Wet is bad: Residual congestion predicts worse prognosis in acute heart failure 89
Scared to Death: Emotional Stress Causing Fatal Myocardial Infarction With Nonobstructed Coronary Arteries in Women 89
Totale 18.004
Salva come PNG Salva come JPEG
Categoria #
all - tutte 214.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 214.066
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202094 0 0 0 0 0 0 0 0 0 0 0 94
2020/20212.357 195 209 96 208 108 321 143 129 217 158 252 321
2021/20222.538 177 295 65 231 108 145 298 491 203 285 52 188
2022/20231.732 162 165 75 154 210 208 42 155 341 43 121 56
2023/20241.762 107 49 336 122 75 154 106 71 88 96 95 463
2024/202519.088 220 243 878 362 665 803 1.951 3.264 1.352 2.531 4.186 2.633
Totale 29.553